危重症成人气管插管时液体推注对心血管崩溃的影响:一项随机临床试验
该随机临床试验纳入美国11个ICU的1067例接受镇静和正压通气下气管插管的危重症成人,比较500 mL静脉液体推注与不推注对心血管崩溃的影响。液体推注组心血管崩溃发生率为21.0%,不推注组为18.2%,绝对差异2.8%(95%CI -2.2%至7.7%;P=0.25),差异未达统计学显著。
要点
- 危重症成人气管插管时,静脉液体推注与不推注相比未显著降低心血管崩溃发生率。
- 液体推注组心血管崩溃21.0%,不推注组18.2%,绝对差异2.8%(95%CI -2.2%至7.7%)。
- 次要结局第28天前死亡(出院删失)两组分别为40.5%和42.3%,差异未达统计学显著。
核心结论
- 在危重症成人气管插管患者中,与不推注液体相比,静脉液体推注未显著降低心血管崩溃的发生率。
研究设计与样本
- 随机临床试验,于2019年2月1日至2021年5月24日在美国11个重症监护病房纳入1067例接受镇静和正压通气下气管插管的危重症成人,最终随访日期为2021年6月21日。
- 患者随机接受500 mL静脉液体推注(n=538)或不推注液体(n=527);1067例随机患者中1065例(99.8%)完成试验并纳入主要分析,中位年龄62岁(IQR 51-70岁),42.1%为女性。
主要发现
- 主要结局心血管崩溃在液体推注组发生113例(21.0%),不推注组发生96例(18.2%),绝对差异2.8%(95%CI -2.2%至7.7%;P=0.25)。
- 新接受或增加血管升压药在液体推注组为20.6%,不推注组为17.6%;收缩压低于65 mm Hg分别为3.9%与4.2%;心脏骤停分别为1.7%与1.5%;死亡分别为0.7%与0.6%。
- 第28天前死亡(出院删失)在液体推注组发生218例(40.5%),不推注组发生223例(42.3%),绝对差异-1.8%(95%CI -7.9%至4.3%;P=0.55)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Hypotension is common during tracheal intubation of critically ill adults and increases the risk of cardiac arrest and death. Whether administering an intravenous fluid bolus to critically ill adults undergoing tracheal intubation prevents severe hypotension, cardiac arrest, or death remains uncertain. OBJECTIVE: To determine the effect of fluid bolus administration on the incidence of severe hypotension, cardiac arrest, and death. DESIGN, SETTING, AND PARTICIPANTS: This randomized clinical trial enrolled 1067 critically ill adults undergoing tracheal intubation with sedation and positive pressure ventilation at 11 intensive care units in the US between February 1, 2019, and May 24, 2021. The date of final follow-up was June 21, 2021. INTERVENTIONS: Patients were randomly assigned to receive either a 500-mL intravenous fluid bolus (n = 538) or no fluid bolus (n = 527). MAIN OUTCOMES AND MEASURES: The primary outcome was cardiovascular collapse (defined as new or increased receipt of vasopressors or a systolic blood pressure <65 mm Hg between induction of anesthesia and 2 minutes after tracheal intubation, or cardiac arrest or death between induction of anesthesia and 1 hour after tracheal intubation). The secondary outcome was the incidence of death prior to day 28, which was censored at hospital discharge. RESULTS: Among 1067 patients randomized, 1065 (99.8%) completed the trial and were included in the primary analysis (median age, 62 years [IQR, 51-70 years]; 42.1% were women). Cardiovascular collapse occurred in 113 patients (21.0%) in the fluid bolus group and in 96 patients (18.2%) in the no fluid bolus group (absolute difference, 2.8% [95% CI, -2.2% to 7.7%]; P = .25). New or increased receipt of vasopressors occurred in 20.6% of patients in the fluid bolus group compared with 17.6% of patients in the no fluid bolus group, a systolic blood pressure of less than 65 mm Hg occurred in 3.9% vs 4.2%, respectively, cardiac arrest occurred in 1.7% vs 1.5%, and death occurred in 0.7% vs 0.6%. Death prior to day 28 (censored at hospital discharge) occurred in 218 patients (40.5%) in the fluid bolus group compared with 223 patients (42.3%) in the no fluid bolus group (absolute difference, -1.8% [95% CI, -7.9% to 4.3%]; P = .55). CONCLUSIONS AND RELEVANCE: Among critically ill adults undergoing tracheal intubation, administration of an intravenous fluid bolus compared with no fluid bolus did not significantly decrease the incidence of cardiovascular collapse. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03787732.
引用
- Russell DW, Casey JD, Gibbs KW, et al. Effect of Fluid Bolus Administration on Cardiovascular Collapse Among Critically Ill Patients Undergoing Tracheal Intubation: A Randomized Clinical Trial. JAMA. 2022. PMID: 35707974. doi:10.1001/jama.2022.9792
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。